206 related articles for article (PubMed ID: 21896780)
1. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.
Ahn YH; Yang Y; Gibbons DL; Creighton CJ; Yang F; Wistuba II; Lin W; Thilaganathan N; Alvarez CA; Roybal J; Goldsmith EJ; Tournier C; Kurie JM
Mol Cell Biol; 2011 Nov; 31(21):4270-85. PubMed ID: 21896780
[TBL] [Abstract][Full Text] [Related]
2. ZPK/DLK and MKK4 form the critical gateway to axotomy-induced motoneuron death in neonates.
Itoh T; Horiuchi M; Ikeda RH; Xu J; Bannerman P; Pleasure D; Penninger JM; Tournier C; Itoh A
J Neurosci; 2014 Aug; 34(32):10729-42. PubMed ID: 25100604
[TBL] [Abstract][Full Text] [Related]
3. Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma.
Chae KS; Ryu BK; Lee MG; Byun DS; Chi SG
Eur J Cancer; 2002 Oct; 38(15):2048-57. PubMed ID: 12376211
[TBL] [Abstract][Full Text] [Related]
4. Map2k4δ - identification and functional characterization of a novel Map2k4 splice variant.
Haeusgen W; Tueffers L; Herdegen T; Waetzig V
Biochim Biophys Acta; 2014 May; 1843(5):875-84. PubMed ID: 24487067
[TBL] [Abstract][Full Text] [Related]
5. MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
Xin W; Yun KJ; Ricci F; Zahurak M; Qiu W; Su GH; Yeo CJ; Hruban RH; Kern SE; Iacobuzio-Donahue CA
Clin Cancer Res; 2004 Dec; 10(24):8516-20. PubMed ID: 15623633
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.
Davis SJ; Choong DY; Ramakrishna M; Ryland GL; Campbell IG; Gorringe KL
BMC Cancer; 2011 May; 11():173. PubMed ID: 21575258
[TBL] [Abstract][Full Text] [Related]
7. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
Liu XD; Zhang ZW; Wu HW; Liang ZY
Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
[TBL] [Abstract][Full Text] [Related]
8. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
Roybal JD; Zang Y; Ahn YH; Yang Y; Gibbons DL; Baird BN; Alvarez C; Thilaganathan N; Liu DD; Saintigny P; Heymach JV; Creighton CJ; Kurie JM
Mol Cancer Res; 2011 Jan; 9(1):25-35. PubMed ID: 21115742
[TBL] [Abstract][Full Text] [Related]
9. Theoretical proposal: allele dosage of MAP2K4/MKK4 could rationalize frequent 17p loss in diverse human cancers.
Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Abdelmohsen K; Gorospe M; Kern SE
Cell Cycle; 2006 May; 5(10):1090-3. PubMed ID: 16721048
[TBL] [Abstract][Full Text] [Related]
10. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
[TBL] [Abstract][Full Text] [Related]
11. Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.
Yeddula N; Xia Y; Ke E; Beumer J; Verma IM
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6476-85. PubMed ID: 26542681
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
13. Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas.
Cortot AB; Younes M; Martel-Planche G; Guibert B; Isaac S; Souquet PJ; Commo F; Girard P; Fouret P; Brambilla E; Hainaut P; Soria JC
Clin Lung Cancer; 2014 Mar; 15(2):124-30. PubMed ID: 24169260
[TBL] [Abstract][Full Text] [Related]
14. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
[TBL] [Abstract][Full Text] [Related]
15. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
Wang L; Pan Y; Dai JL
Oncogene; 2004 Aug; 23(35):5978-85. PubMed ID: 15184866
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
Chen HW; Lee JY; Huang JY; Wang CC; Chen WJ; Su SF; Huang CW; Ho CC; Chen JJ; Tsai MF; Yu SL; Yang PC
Cancer Res; 2008 Sep; 68(18):7428-38. PubMed ID: 18794131
[TBL] [Abstract][Full Text] [Related]
17. Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
Maity TK; Venugopalan A; Linnoila I; Cultraro CM; Giannakou A; Nemati R; Zhang X; Webster JD; Ritt D; Ghosal S; Hoschuetzky H; Simpson RM; Biswas R; Politi K; Morrison DK; Varmus HE; Guha U
Cancer Discov; 2015 May; 5(5):534-49. PubMed ID: 25735773
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway.
Xia D; Srinivas H; Ahn YH; Sethi G; Sheng X; Yung WK; Xia Q; Chiao PJ; Kim H; Brown PH; Wistuba II; Aggarwal BB; Kurie JM
J Biol Chem; 2007 Feb; 282(6):3507-19. PubMed ID: 17158870
[TBL] [Abstract][Full Text] [Related]
19. Mutation rate of MAP2K4/MKK4 in breast carcinoma.
Su GH; Song JJ; Repasky EA; Schutte M; Kern SE
Hum Mutat; 2002 Jan; 19(1):81. PubMed ID: 11754110
[TBL] [Abstract][Full Text] [Related]
20. Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.
Tennis MA; Van Scoyk MM; Freeman SV; Vandervest KM; Nemenoff RA; Winn RA
Mol Cancer Res; 2010 Jun; 8(6):833-43. PubMed ID: 20501643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
